The Gujarat Health Department is set to initiate the third phase of the Mass Drug Administration (MDA) program targeting filariasis from February 10 to 12. This campaign will cover four talukas in Bharuch, Narmada, and Dang districts, aiming to combat elephantiasis, also known as lymphatic filariasis, aligning with the national goal to eradicate the disease by 2030.
The MDA drive will specifically focus on Netrang taluka in Bharuch district, Nandod and Dediapada talukas in Narmada district, and Waghai taluka in Dang district. Over 5.48 lakh individuals are expected to benefit from this program across the designated talukas.
In Gujarat, 17 districts in Saurashtra and South Gujarat have been identified as filariasis-sensitive areas. Night blood surveys conducted in previously non-endemic regions revealed the presence of filarial parasites, leading to the inclusion of the four talukas in the MDA initiative.
As part of the campaign, eligible individuals will receive anti-filarial medications, Diethylcarbamazine (DEC) and Albendazole, to eliminate parasites from their bodies. The drug administration will exclude children under two years old, pregnant women, critically ill persons, and lactating mothers within one week of delivery.
